The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

‘I believe that validated PET-imaging biomarkers could transform the future clinical cancer care’

Wallenberg Molecular Medicine Clinical Researcher - Elin Trägårdh

The focus of senior consultant Elin Trägårdh’s research is diagnostic nuclear medicine – in particular a modality called PET/CT. It is used mainly for evaluation of patients with cancer. Today, PET/CT is reviewed manually by doctors. ”I think we don't use all the information there is in the images. What if we could use artificial intelligence to help us to quantify the images and obtain as much information as possible?”

Elin Trägårdh is a senior consultant in nuclear medicine at Skåne University Hospital and a researcher at Wallenberg Centre for Molecular Medicine (WCMM). In 2022, every week a researcher working at WCMM at Lund University and Skåne University Hospital is presented. In the video, Elin Trägårdh shares more about her research.

About Wallenberg Centre for Molecular Medicine 

  • Wallenberg Centre for Molecular Medicine (WCMM) is a research centre focused on Regenerative and Translational Medicine.
  • Through integrated research environments and excellent infrastructure, conditions are created for world-leading molecular and translational research.
  • The research at the Wallenberg Centre for Molecular Medicine was made possible by generous funding from the Knut and Alice Wallenberg Foundation, the Region Skåne and the Faculty of Medicine at Lund University. The Knut and Alice Wallenberg Foundation is making a nationwide effort to ensure that Sweden regains a world-leading position in medical research.